Akeso, Inc.

Status: Publicly traded

Direct answer

Akeso, Inc. is publicly traded on HKSE under the ticker 9926.HK.

Akeso, Inc. is a biopharmaceutical enterprise dedicated to the discovery, development, manufacturing, and commercialization of therapeutic solutions. The company boasts a diverse pipeline, with a significant focus on oncology. Its cancer-focused treatments include AK104, a PD-1/CTLA-4 bi-specific antibody in development for various malignancies such as cervical cancer, gastric cancer (GC), gastroesophageal junction...

Can you invest in Akeso, Inc.?

Yes. Akeso, Inc. is publicly traded on HKSE under the ticker 9926.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Akeso, Inc.

Detailed equity research is provided by MarketSnap.